Ovid Therapeutics Inc. · NASDAQ:OVID
Point72 Asset Management, L.P.'s stake in Ovid Therapeutics Inc. fell to 1.30% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in Ovid Therapeutics Inc. fell to 1.30%, 1,903,943 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 1.30%
- Shares
- 1,903,943
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 1.30% | 1,903,943 |
| Point72 Capital Advisors, Inc. | 1.30% | 1,903,943 |
| Steven A. Cohen | 1.30% | 1,903,943 |
Source
Related
- Ovid Therapeutics Inc.
- Point72 Asset Management, L.P.
- Ovid Therapeutics Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Jan 5, 2026
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026